Goldman Sachs
DPLO

Goldman Sachs’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Goldman Sachs’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$2K – 6573
2017
Q4 		$2K Sell
100
-600
-86% -$11.8K ﹤0.01% 6284
2017
Q3 		$14K Sell
700
-400
-36% -$6.76K ﹤0.01% 6492
2017
Q2 		$16K Sell
1,100
-200
-15% -$3.33K ﹤0.01% 6595
2017
Q1 		$21K Buy
1,300
+200
+18% +$2.88K ﹤0.01% 6506
2016
Q4 		$14K Sell
1,100
-900
-45% -$16.8K ﹤0.01% 6720
2016
Q3 		$56K Buy
2,000
+900
+82% +$30.2K ﹤0.01% 6438
2016
Q2 		$39K Buy
1,100
+400
+57% +$12.6K ﹤0.01% 6508
2016
Q1 		$19K Sell
700
-1,400
-67% -$41.2K ﹤0.01% 6765
2015
Q4 		$72K Sell
2,100
-33,300
-94% -$1.04M ﹤0.01% 6351
2015
Q3 		$1.02M Buy
35,400
+16,800
+90% +$718K ﹤0.01% 4461
2015
Q2 		$832K Buy
+18,600
New +$700K ﹤0.01% 4704

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Goldman Sachs's DPLO Position: Q1 2020 in Review

Goldman Sachs sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 563,003 shares — an estimated $2.25M sold.

Goldman Sachs first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $8.86M in Q1 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Goldman Sachs reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Goldman Sachs sold 563,003 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $2.25M.
  • Goldman Sachs first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
  • Goldman Sachs's DIPLOMAT PHARMACY, INC. position peaked at $8.86M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.